Background: Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is a chronic
| INTRODUCTION

Chronic rhinosinusitis (CRS) is a very common disease, reportedly
affecting approximately 12% of the general population 1 with significant direct medical costs. CRS is defined in adults as a local inflammation of the nasal and paranasal sinus mucosae with symptoms including nasal congestion, loss of smell, rhinorrhea, and facial pain that persists for at least 12 consecutive weeks. 1 There are two main phenotypes of CRS: CRS with nasal polyps (CRSwNP), which typically has an eosinophilic component, and CRS without nasal polyps (CRSsNP), which has a neutrophilic component. 2 Although the causes of CRSwNP are still unclear, suspected pathogenic mechanisms include an innate barrier defect, primary infections that damage the mucosal barrier and promote its permeability, and dysfunction of several components of immunity. 3 Although still a matter of debate, 4 fungal colonization has been proposed to promote dysregulation of the sinonasal micro-
biome. Association of CRSwNP with local colonization by
Staphylococcus aureus has been reported, 5 and the toxins secreted by S. aureus that act as superantigens have been shown to amplify immune responses and shift inflammation toward the type 2/T helper type 2 cell (Th2) profile, including eosinophil infiltration and activation. [6] [7] [8] While systemic atopy is not strongly associated with CRSwNP, elevations of IgE in nasal secretions and tissue indicate a localized allergic condition. 3 Levels of IgE antibodies to Staphylococcal enterotoxin superantigens in nasal polyp tissue are thought to be related to disease severity. [5] [6] [7] It is generally well accepted that the immune system plays a major role in CRS development. 2, 3, 9 Infiltration of innate immune cells and increased levels of pro-inflammatory chemokines and cytokines have been detected in nasal polyps of CRS patients. 3 The injured epithelium releases cytokines interleukin IL-25 and IL-33, and thymic stromal lymphopoietin (TSLP), collectively known as alarmins, which direct Th2-polarized inflammatory response by inducing the production of type 2 cytokines, IL-5, IL-4, and IL-13. 
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INVESTIGATING SENSE OF SMELL IN ALLERGIC CRS MOUSE MODEL
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G R A P H I C A L A B S T R A C T
Mice intranasally exposed to house dust mite extract + staphylococcus aureus enterotoxin B develop allergic chronic sinusitis (CRS) with a local type 2/Th2 response. Type 2/Th2 cytokine release associates with eosinophil and mast cell infiltration, decreased immature OSN in the olfactory epithelium, and no loss of smell. Although sense of smell did not appear to be altered in this model, the data reveal the influence of chronic inflammation on olfactory neurogenesis Patients with CRS generally suffer from many symptoms, including nasal obstruction, congestion, nasal discharge, facial pressure and pain, headache, and reduction or even loss of smell (hyposmia or anosmia, respectively).
2 Impairment in sense of smell, one of the most troublesome symptoms in patients with CRSwNP, is correlated with disease severity and may be the first sign of disease reoccurrence. 10 This particular symptom has a substantial impact on quality of life and is often overlooked in disease management. Table 1) . Expression of the chemokine eotaxin 1 was dramatically and significantly increased (10-fold; P < 0.001 compared to control group) ( Table 1 ). mRNA analysis of additional inflammatory markers in the HDM + SEB-treated OE compared to control OE further revealed an upward trend for the expression of alarmins (eg, IL-25 and TSLP), a significant (P < 0.001) increase in IL-13 receptor subunits (6.8-fold in IL-13Rα 2 and 1.3-fold in IL-13Rα 1 , Table 1 ), and a significant increase in IL-10 (1.7-fold; P < 0.001).
These data were corroborated by protein titration (Figure 2A ),
showing a significant increase (P < 0.0001) in IL-13 and IL-5 in the Data are expressed as a fold change (FC) between the ΔCT of HDM + SEB-treated mice and ΔCT of vehicle-treated mice. Statistical differences between groups were assessed using the Wilcoxon-Mann-Whitney U test, and P values below P < 0.05 were considered statistically significant. CT, cycle threshold; HDM, house dust mite; OE, olfactory epithelium; OMP, olfactory marker protein; PAS, Per-Arnt-Sim; SEB, Staphylococcal enterotoxin type B; TSLP, thymic stromal lymphopoietin. ***P < 0.001 vs controls. **P < 0.01 vs controls.
HDM + SEB-treated group vs control group (IL-13: 6. Statistical analysis was performed using a Wilcoxon-Mann-Whitney U test, and P values below P < 0.05 were considered statistically significant. ***P < 0.001 vs controls. ELISA, enzyme-linked immunosorbent assay; HDM, house dust mite; IL, interleukin; ns, not significant; OE, olfactory epithelium
F I G U R E 3 Eosinophils and mast cell counts in (A) olfactory mucosa and in (B) respiratory mucosa. Eosinophil infiltration was evaluated using Sirius red staining and quantified by pixel count (number of red pixels/total number of pixels) and expressed as a percentage in an olfactory or respiratory area previously defined. Mast cells were stained based on IHC using mast cell tryptase antibody. Positive cells were counted as a number of cells per squared millimeter. Graphs represent median with interquartile range of eight mice (plots) for each group. Statistical differences between groups were assessed using the Wilcoxon-Mann-Whitney U test, and P values below P < 0.05 were considered statistically significant. (C) Sirius red staining of a vehicle animal at low magnification with higher magnification inset. (D) Sirius red staining of an HDM + SEB animal at low magnification with higher magnification inset. Pink circles indicate areas of eosinophil infiltration. ***P < 0.001 vs controls. HDM, house dust mite; IHC, immunohistochemistry; SEB, Staphylococcal enterotoxin type B was significantly (P < 0.0001) increased in the OE (22.4 ± 3.9 ng/mg vs 3.1 ± 0.2 ng/mg for the HDM + SEB-treated group vs control group). In addition, IgE was the only inflammatory marker found elevated in serum (24,393 ± 1613 ng/mL vs 6989 ± 1783 ng/mL for the HDM + SEB-treated group vs control group, Figure 2B ). Number of mature olfactory neurons and (C) immature olfactory neurons in OE. Mature olfactory neurons were stained by IHC using OMP antibody and quantified by pixel count (brown pixels/total pixel number) and expressed as a percentage. Immature olfactory neurons were stained by IHC using GAP43 antibody and counted as a number of cells per squared millimeter. Graphs represent median with interquartile range of 7-8 mice (plots) for each group. Statistical differences between groups were assessed using the Wilcoxon-Mann-Whitney U test, and P values below P < 0.05 were considered statistically significant. (D) GAP43 IHC at low magnification in a vehicle animal. (E) GAP43 IHC at low magnification in an HDM + SEB animal. *P < 0.05 vs controls. GAP43, growth-associated protein 43; HDM, house dust mite; IHC, immunohistochemistry; NS, not significant; OE, olfactory epithelium; OMP, olfactory marker protein; SEB, Staphylococcal enterotoxin type B allergic OE: Mast cells were located into the epithelium layer, whereas eosinophils were observed within the lamina propria, near to the nerve bundle ( Figure 4A ).
| HDM + SEB treatment affects olfactory mucosa structure
The impact of allergen treatment on the olfactory markers was further analyzed. Expression levels of the olfactory marker protein (OMP), which is uniquely associated with mature OSNs, were not significantly different between groups (fold change [FC] = 1.1). In contrast, a significant decrease in expression levels of growth-associated protein 43 (GAP43), a marker of immature OSNs, was observed in the HDM + SEB-treated group (0.4-fold, P < 0.001) compared to controls ( Table 1) . Immunolabeling of mature and immature OSNs also supported a differential response of these populations. In HDM + SEB-treated mice, the number of mature OMPpositive OSNs was unchanged in the OE (1.7 ± 0.3% for HDM + SEB-treated group vs 1.5 ± 0.2% for control group), whereas there was a significant (P < 0.05) reduction in the number of immature GAP43-positive OSNs (1145 ± 271 cells/mm² for HDM + SEB group vs 2067 ± 617 cells/mm² for control group; P < 0.05; Figure 4B -E).
Additional transcriptomic hallmarks indicated a 0.6-fold reduction in the expression of NEUROG1, a marker of globose basal cells (GBC)
in HDM + SEB group compared to control (P < 0.001; Table 1 ). In contrast, expression of the horizontal basal cell (HBC) markers TRP63 and RGS1 was slightly increased compared to controls (1.4-fold and 1.6-fold, respectively).
| HDM + SEB treatment does not induce OSN dysfunction and loss of smell
The heptanal-evoked electro-olfactogram (EOG) characteristically displayed a fast depolarization of approximately 1 mV in amplitude followed by a slow and progressive repolarization lasting about 10 seconds ( Figure 5A ). Electro-olfactograms amplitudes observed in each group were not significantly different (P = 0.4536) overall heptanal doses tested ( Figure 5B ).
After 22 weeks of allergen treatment, a buried food test was performed and the median latency to discover the hidden food in HDM + SEB-treated mice group was not significantly different compared to control mice (P = 0.4365) ( Figure 5C ).
The performance of the mice changed over the course of the study. The latency to discover hidden food declined over time in both HDM + SEB-treated and control groups ( Figure 5C ). A sham trial was performed as a negative control at Week 13, with an odorfree polystyrene pellet; mice were unable to find this odor-free pellet (latency of 900s ± 0 median absolute deviation) ( Figure 5C ),
F I G U R E 5 Characterization of sense of smell (A) typical recordings of 10% heptanal-evoked EOGs of OSNs from vehicle-treated and HDM + SEB-treated mice. Black arrows indicate odorant (heptanal 10%) stimulation (100 ms). (B) EOG responses to increasing odorant percentage in vehicle and HDM + SEB groups.
Values represent the means of peak amplitudes ± SEM (n = 7-8/group), normalized to the response to 100% heptanal. (C) Buried food test. Bar graph represents the time course of median latency to discover a hidden food ± MAD in the vehicle and HDM + SEB-treated groups (n = 38/group). In the Week 13_Sham experiment, mice had to discover a food pellet without odorant. The inset shows the latency distribution in Week 22 for both groups. Graphs represent median with interquartile range of 38 mice (plots) for each group. EOG, electro-olfactograms; HDM, house dust mite; MAD, median absolute deviation; OSN, olfactory sensory neurons; SEB, Staphylococcal enterotoxin type B suggesting that mice relied on their sense of smell to find buried pellets and that they were not overtrained to burrow and find any object regardless of its odor.
| DISCUSSION
To our knowledge, this study is the first to evaluate the impact of inflammation on both sense of smell and olfactory neurogenesis in a mouse model of allergic CRS. Mice treated for 22 weeks with a combination of HDM + SEB showed an elevation of several type 2/Th2 markers, as measured by transcriptomic and biochemical analyses.
This elevation was concomitant with changes in other transcriptomic and histology markers revealing a decrease of immature olfactory neuron number and renewal, without affecting the sense of smell of mice as measured by EOG and behavioral food test.
In our present study, we combined and adapted the mouse models developed by Kim et al 19 and Khalmuratova et al. 20 In order to induce a robust type 2/Th2 inflammatory profile, the impact of several factors (eg, mouse strain, type of allergen, anesthesia, sex, age, and stress 21 ) that could modulate allergy development following airway exposure of nonsensitized laboratory rodents to antigen was considered in our experimental procedure. BALB/cByJ female mice were chosen because it has been established that they have a more pronounced type 2/Th2 response in dermatitis or airway allergy inflammation models. 22, 23 However, the impact of allergen exposure regimen (dose and duration) on tolerance, a reaction that can occur during a long period of continuous allergen administration, was more difficult to ascertain. To decrease tolerance, we introduced an interruption in the allergen (HDM) administration and monitored IL-10 mRNA levels, which are known as a tolerogenic marker. However, after the immunization pause, IL-10 mRNA levels were still up-regulated, while type 2/Th2 markers remained elevated. These data are in good agreement with those of a long-term study by Kim et al., 24 where mice treated with OVA + SEB presented increased type 2/ Th2 inflammation markers despite a twofold increase in IL-10 cytokine levels, suggesting an incomplete immune tolerance mechanism.
House dust mite is an allergen rarely used to induce allergic CRS in animals, but, as shown by Khalmuratova et al 20 its use may represent an improvement of CRS models, as HDM induces a more robust inflammatory profile than OVA, enhances the infiltration of mast cells known to be involved in the development of CRSwNP, and is more relevant to human disease than OVA.
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In their HDM CRS murine model study, 20 Khalmuratova et al reported an elevation of total serum IgE, as well as increased eosinophil and mast cell numbers in the nasal mucosa. Further describing this model, our transcriptomic analysis showed an increase in inflammatory markers related to type 2/Th2 inflammation in the OE (Table 1) , including IL-4, IL-13, and IL-5 mRNA levels. These results were confirmed at the protein level. In contrast, no change in the level of these three cytokines was observed in the serum. These results strongly suggest that our CRS mice model presents a type 2/ Th2 inflammatory profile restricted to the nasal cavity. Focusing on the OE and combining two different stimuli (protease activity with HDM and bacterial protein with SEB), we found a strong increase in IL-33 receptor (ST2) mRNA and a slight increase in IL-25 mRNA without affecting TSLP and IL-33 mRNA levels (Table 1 ). In our model, the cellular sources of cytokine release have yet to be determined. Recently, in a short-term (3 months) mouse model where CRSwNP was induced by OVA and SEB, a correlation between the up-regulation of IL-25 and TSLP was observed, suggesting that IL-25 could drive TSLP release, leading to type 2/Th2 inflammation. However, this result was not reported in a long-term (6 months) model. 24 These observations pointed to these innate inflammatory markers as participants in the early stages of the disease that drive inflammation toward type 2/Th2 response. It is now clearly established in the literature that innate inflammation markers (eg, alarmin molecules such as IL-25, TSLP, and IL-33) are involved in the generation of CRS. 9, 26 In our present study, the structure of the OE was similar when comparing HDM + SEB-treated and control groups, while previous studies have reported differences. 20, 24 The thickness of the OE was unchanged, in contrast to the data shown by Khalmuratova et al. 20 This discrepancy could possibly be due to the fact that we measured the thickness of the mature olfactory neuron layer, whereas Khalmuratova et al 20 investigated the subepithelial layer. Further, nasal polypoid lesions described by Kim et al 24 were not observed in our HDM + SEB-treated group, and this was corroborated by qPCR analysis, showing low B-cell activating factor (BAFF) mRNA levels and no modification of A proliferation-inducing ligand (APRIL) mRNA, both markers of nasal polyps in humans and mice. 27 Histological differences were observed between control and HDM + SEB-treated groups. Olfactory mucosa from HDM + SEBtreated animals displayed a significant reduction in the number of immature OSNs. This observation was further correlated with the decreased expression of GAP43 mRNA, which encodes a protein believed to be involved in the growth and development of immature neurons. 28 Reduced expression of GAP43 has been associated with impaired development and maturation of olfactory neurons in severe neurotoxic or inflammatory conditions. 16, 29 Elevations in TNF release are known to induce apoptosis of immature and mature OSNs. 29, 30 However, in our present study, we did not observe any change in TNF mRNA (Table 1) OSNs, in the OE. 39 Nevertheless, the link between OSN number and sense of smell has not been clearly determined in the literature.
Furthermore, it has been proposed that eosinophil infiltrations are involved in sense of smell deficiency. AR mouse models have evaluated the differences in eosinophil infiltration between respiratory epithelium and OE. 16, 38, 40, 41 These models used OVA or A. fumigatus as allergens and presented that eosinophils infiltrated or did not infiltrate the OE, or were limited to the respiratory-olfactory epithelia transition.
These discrepancies can be explained by various factors, including the amount of allergen, immunization time course, and induction of an allergic response coupled or not with innate inflammation. In CRS animal models, the use of different allergens (eg, OVA/HDM with or without SEB) and sensitization protocol 19, 20 focused on nasal cavities without any distinction between olfactory and respiratory epithelia.
In our present work, eosinophils in the HDM + SEB-treated group were more present in the respiratory than in the olfactory area; this may result from a greater number of epithelial cells releasing alarmins and eosinophil-attracting chemokines in that region. Interestingly, eosinophils in OE were mainly observed in the subepithelial compartment (lamina propria), at times near to nerve bundles which was also observed by Carr et al. 40 Given that eosinophil granules are neurotoxic, 42 cell subpopulation ratios display some differences. 44 For example, the total number of olfactory neurons is much higher in mice than in humans 45 and could explain why olfactory function in rodents appears to be more resistant to inflammatory challenges.
In conclusion, our study presents a mouse model of allergic CRS 
